HUB Hôpital Erasme

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Friedreich ataxia1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Status

• Active, not recruiting2 trials
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Biogen1 trial
• Erasme University Hospital1 trial
• Helsinki University Central Hospital1 trial
• Novo Nordisk A/S1 trial

Running trials

• Recruiting

  A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

  NCT06623890· Biogen· Source

  Contact: Naeije Gilles (principal investigator)

• Active, not recruiting

  CGM Boosted by Artificial Intelligence for Better Glycaemic Control in T2 Diabetes

  NCT07064499· Erasme University Hospital· Source

• Active, not recruiting

  Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)

  NCT07579390· Helsinki University Central Hospital· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Friedreich ataxia1 recruiting

Closed trials

• Completed

  A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice

  NCT05069545· Novo Nordisk A/S· Source